PR-Section 8 and 9

COLAZAL

Salix Pharmaceuticals, Inc.

Combined Declaration of Use and/or Excusable Nonuse/Application for Renewal of Registration of a Mark under Sections 8 & 9

PTO- 1963
Approved for use through 01/31/2025. OMB 0651-0055
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Combined Declaration of Use and/or Excusable Nonuse/Application for Renewal of Registration of a Mark under Sections 8 & 9


The table below presents the data as entered.

Input Field
Entered
REGISTRATION NUMBER 2534845
REGISTRATION DATE 01/29/2002
SERIAL NUMBER 76025821
MARK SECTION
MARK COLAZAL (see, mark)
ATTORNEY INFORMATION (current)
NAME Robert J. Gorman
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
INTERNAL ADDRESS Law Department
STREET 1400 N. Goodman Street
CITY Rochester
STATE New York
POSTAL CODE 14609
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
PHONE 585-338-8049
EMAIL trademarks@bausch.com
ATTORNEY INFORMATION (proposed)
NAME Robert J. Gorman
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
INTERNAL ADDRESS Law Department
STREET 1400 N. Goodman Street
CITY Rochester
STATE New York
POSTAL CODE 14609
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
PHONE 585-338-8049
EMAIL trademarks@bausch.com
OTHER APPOINTED ATTORNEY Evan S. Fultz
CORRESPONDENCE INFORMATION (current)
NAME Robert J. Gorman
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE trademarks@bausch.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) holly.smith@bausch.com
CORRESPONDENCE INFORMATION (proposed)
NAME Robert J. Gorman
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE trademarks@bausch.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) holly.smith@bausch.com
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 005
GOODS OR SERVICES PHARMACEUTICAL PREPARATIONS FOR THE PREVENTION AND TREATMENT OF GASTROINTESTINAL DISEASES
       SPECIMEN FILE NAME(S)
       ORIGINAL PDF FILE SPN0-454619393-2022012817 0019313353_._Colazal-PI.pdf
       CONVERTED PDF FILE(S)
       (19 pages)
\\TICRS\EXPORT18\IMAGEOUT 18\760\258\76025821\xml4\ S890002.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\760\258\76025821\xml4\ S890003.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\760\258\76025821\xml4\ S890004.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\760\258\76025821\xml4\ S890005.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\760\258\76025821\xml4\ S890006.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\760\258\76025821\xml4\ S890007.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\760\258\76025821\xml4\ S890008.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\760\258\76025821\xml4\ S890009.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\760\258\76025821\xml4\ S890010.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\760\258\76025821\xml4\ S890011.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\760\258\76025821\xml4\ S890012.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\760\258\76025821\xml4\ S890013.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\760\258\76025821\xml4\ S890014.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\760\258\76025821\xml4\ S890015.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\760\258\76025821\xml4\ S890016.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\760\258\76025821\xml4\ S890017.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\760\258\76025821\xml4\ S890018.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\760\258\76025821\xml4\ S890019.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\760\258\76025821\xml4\ S890020.JPG
SPECIMEN DESCRIPTION product information leaflet included in the product packaging clearly showing the mark used for the goods
        WEBPAGE URL None Provided
        WEBPAGE DATE OF ACCESS None Provided
OWNER SECTION (current)
NAME Salix Pharmaceuticals, Inc.
INTERNAL ADDRESS 400 Somerset Corporate Blvd.
MAILING ADDRESS Legal Dept.
CITY Bridgewater
STATE New Jersey
ZIP/POSTAL CODE 08807
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
PHONE 585-338-8049
FAX 585-338-0015
EMAIL XXXX
OWNER SECTION (proposed)
NAME Salix Pharmaceuticals, Inc.
INTERNAL ADDRESS 400 Somerset Corporate Blvd.
MAILING ADDRESS Legal Dept.
CITY Bridgewater
STATE New Jersey
ZIP/POSTAL CODE 08807
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
PHONE 585-338-8049
FAX 585-338-0015
EMAIL XXXX
LEGAL ENTITY SECTION (current)
TYPE corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION California
PAYMENT SECTION
NUMBER OF CLASSES 1
NUMBER OF CLASSES PAID 1
COMBINED §§ 8 & 9 DECLARATION/APPLICATION FILING FEE 525
TOTAL FEE PAID 525
SIGNATURE SECTION
SIGNATURE /Holly Smith/
SIGNATORY'S NAME Holly Smith
SIGNATORY'S POSITION Trademark Legal Operations Manager
DATE SIGNED 01/28/2022
SIGNATORY'S PHONE NUMBER 585-338-8049
SIGNATURE METHOD Signed directly within the form
PAYMENT METHOD DA
FILING INFORMATION
SUBMIT DATE Fri Jan 28 17:07:11 ET 2022
TEAS STAMP USPTO/S08N09-XX.XX.XXX.XX
-20220128170711721942-253
4845-8001e9e2d3449ddc431e
9fd9f77494b32d5c7f1cf14fb
d9b7764d32d2b51770c1-DA-0
7094401-20220128170019313
353



PTO- 1963
Approved for use through 01/31/2025. OMB 0651-0055
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Combined Declaration of Use and/or Excusable Nonuse/Application for Renewal of Registration of a Mark under Sections 8 & 9


To the Commissioner for Trademarks:

REGISTRATION NUMBER: 2534845
REGISTRATION DATE: 01/29/2002

MARK: COLAZAL

Current: The owner, Salix Pharmaceuticals, Inc., a corporation of California, having an address of
      Legal Dept. 400 Somerset Corporate Blvd.
       Bridgewater, New Jersey 08807
      United States
      XXXX
      585-338-8049
      585-338-0015

Proposed: The owner, Salix Pharmaceuticals, Inc., a corporation of California, having an address of
      400 Somerset Corporate Blvd.
      Legal Dept.
      Bridgewater, New Jersey 08807
      United States
      585-338-8049
      585-338-0015
      XXXX
is filing a Combined Declaration of Use and/or Excusable Nonuse/Application for Renewal of Registration of a Mark under Sections 8 & 9.

For International Class 005, the mark is in use in commerce on or in connection with all goods/services, or to indicate membership in the collective membership organization, listed in the existing registration for this specific class: PHARMACEUTICAL PREPARATIONS FOR THE PREVENTION AND TREATMENT OF GASTROINTESTINAL DISEASES ; or, the owner is making the listed excusable nonuse claim.

The owner is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in this class, consisting of a(n) product information leaflet included in the product packaging clearly showing the mark used for the goods.

Original PDF file:
SPN0-454619393-2022012817 0019313353_._Colazal-PI.pdf
Converted PDF file(s) (19 pages)
Specimen File1
Specimen File2
Specimen File3
Specimen File4
Specimen File5
Specimen File6
Specimen File7
Specimen File8
Specimen File9
Specimen File10
Specimen File11
Specimen File12
Specimen File13
Specimen File14
Specimen File15
Specimen File16
Specimen File17
Specimen File18
Specimen File19

Webpage URL: None Provided
Webpage Date of Access: None Provided
The owner's/holder's current attorney information: Robert J. Gorman. Robert J. Gorman is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, is located at

      Law Department
      1400 N. Goodman Street
      Rochester, New York 14609
      United States

The phone number is 585-338-8049.

The email address is trademarks@bausch.com

The owner's/holder's proposed attorney information: Robert J. Gorman. Other appointed attorneys are Evan S. Fultz. Robert J. Gorman is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at

      Law Department
      1400 N. Goodman Street
      Rochester, New York 14609
      United States

The phone number is 585-338-8049.

The email address is trademarks@bausch.com

Robert J. Gorman submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.Correspondence Information (current):
      Robert J. Gorman
      PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@bausch.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): holly.smith@bausch.com
Correspondence Information (proposed):
      Robert J. Gorman
      PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@bausch.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): holly.smith@bausch.com

Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).

A fee payment in the amount of $525 will be submitted with the form, representing payment for 1 class(es), plus any additional grace period fee, if necessary.


Declaration

Unless the owner has specifically claimed excusable nonuse, the mark is in use in commerce on or in connection with the goods/services or to indicate membership in the collective membership organization identified above, as evidenced by the attached specimen(s).
Unless the owner has specifically claimed excusable nonuse, the specimen(s) shows the mark as currently used in commerce on or in connection with the goods/services/collective membership organization.
The registrant requests that the registration be renewed for the goods/services/collective organization identified above.
To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support.
The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of this submission and the registration, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.

Signature: /Holly Smith/    Date: 01/28/2022
Signatory's Name: Holly Smith
Signatory's Position: Trademark Legal Operations Manager
Signatory's Phone: 585-338-8049
Signature method: Signed directly within the form


Mailing Address (current):
   
   1400 N. Goodman Street
   Rochester, New York 14609

Mailing Address (proposed):
   
   1400 N. Goodman Street
   Rochester, New York 14609

Serial Number: 76025821
Internet Transmission Date: Fri Jan 28 17:07:11 ET 2022
TEAS Stamp: USPTO/S08N09-XX.XX.XXX.XX-20220128170711
721942-2534845-8001e9e2d3449ddc431e9fd9f
77494b32d5c7f1cf14fbd9b7764d32d2b51770c1
-DA-07094401-20220128170019313353

PR-Section 8 and 9 [image/jpeg]

PR-Section 8 and 9 [image/jpeg]

PR-Section 8 and 9 [image/jpeg]

PR-Section 8 and 9 [image/jpeg]

PR-Section 8 and 9 [image/jpeg]

PR-Section 8 and 9 [image/jpeg]

PR-Section 8 and 9 [image/jpeg]

PR-Section 8 and 9 [image/jpeg]

PR-Section 8 and 9 [image/jpeg]

PR-Section 8 and 9 [image/jpeg]

PR-Section 8 and 9 [image/jpeg]

PR-Section 8 and 9 [image/jpeg]

PR-Section 8 and 9 [image/jpeg]

PR-Section 8 and 9 [image/jpeg]

PR-Section 8 and 9 [image/jpeg]

PR-Section 8 and 9 [image/jpeg]

PR-Section 8 and 9 [image/jpeg]

PR-Section 8 and 9 [image/jpeg]

PR-Section 8 and 9 [image/jpeg]

PR-Section 8 and 9 [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed